How a new drug moves through the body in healthy men
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study tests a new drug to see how it is absorbed, distributed, and removed from the body. It is given as a shot to healthy men, and the results will help determine the right dose for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy man between 18 and 50 years old.
- Have a body weight between 60 and 100 kg and a body mass index (BMI) between 18.5 and 30.
- Be in good general health, with normal vital signs, lab tests, and heart rhythm.
- Agree to use contraception or remain abstinent for at least 3 months after the study.
- Have no prior use of certain immune-system drugs (like abatacept, pembrolizumab, or ipilimumab).
- Have no recent infections, vaccines, or significant medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral medication, VG290131, in healthy volunteers to see how the body processes it and if it is safe. It is an early-phase trial that requires participants to be in good health and follow specific rules about medications and lifestyle.
This study tests how a new drug (BMS-986435) is absorbed by the body and whether food changes that. It is for healthy volunteers to help understand the right dose for future patients.
This study tests how eating food changes how your body absorbs a new experimental drug called VV913. Researchers will give you the drug with and without food to see if meals make a difference in how well it works.
This trial studies a new investigational drug called MRM-3379 in healthy men. It uses a tiny amount of a radioactive marker to track how the drug moves through the body, how it's broken down, and how it leaves. Participating helps researchers learn how to dose the drug safely in future studies.
This trial tests a new drug, TL-001, in healthy volunteers to see if it is safe and how the body processes it. You may join if you are a healthy adult between 18 and 55.
This trial is testing a new study drug called LAD106 to see if it is safe in healthy adults. It helps researchers learn how the drug works in the body before moving on to patients with a specific condition.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.